The weekly litigation news digest is live. Subscribe now

IP Verse

Protein Delivery In Primary Hematopoietic Cells - EP3250693

The patent EP3250693 was granted to The Regents OF The University OF California on Dec 20, 2023. The application was filed on Jan 29, 2016 under application number EP16744244A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3250693

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Application Number
EP16744244A
Filing Date
Jan 29, 2016
Status
Patent Maintained As Amended
Nov 17, 2023
Publication Date
Dec 20, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
JAMES POOLEFeb 28, 2022CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (4) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2014287509
INTERNATIONAL-SEARCH-REPORTUS2014357530
OPPOSITIONWO2016021972
SEARCHWO2014191128

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents